{"organizations": [], "uuid": "052a53b4462bc468de6070a4acfbc7a8d61c90f6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180426.html", "section_title": "Archive News &amp; Video for Thursday, 26 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-foundation-medicines-new-liquid-bi/brief-foundation-medicines-new-liquid-biopsy-assay-granted-breakthrough-device-designation-by-u-s-fda-idUSFWN1S30VT", "country": "US", "domain_rank": 408, "title": "Foundation Medicine's New Liquid Biopsy Assay Granted Breakthrough Device Designation By U.S. FDA", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.217, "site_type": "news", "published": "2018-04-26T19:10:00.000+03:00", "replies_count": 0, "uuid": "052a53b4462bc468de6070a4acfbc7a8d61c90f6"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-foundation-medicines-new-liquid-bi/brief-foundation-medicines-new-liquid-biopsy-assay-granted-breakthrough-device-designation-by-u-s-fda-idUSFWN1S30VT", "ord_in_thread": 0, "title": "Foundation Medicine's New Liquid Biopsy Assay Granted Breakthrough Device Designation By U.S. FDA", "locations": [], "entities": {"persons": [{"name": "grante", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters) - foundation medicine inc", "sentiment": "neutral"}, {"name": "foundation medicine's new liquid biopsy assay", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 26 (Reuters) - Foundation Medicine Inc:\n* FOUNDATION MEDICINEâ€™S NEW LIQUID BIOPSY ASSAY GRANTED BREAKTHROUGH DEVICE DESIGNATION BY U.S. FOOD AND DRUG ADMINISTRATION\n* FOUNDATION MEDICINE- NEW ASSAY WILL INCLUDE OVER 70 GENES, GENOMIC BIOMARKERS FOR MICROSATELLITE INSTABILITY & BLOOD TUMOR MUTATIONAL BURDEN Source text for Eikon:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-26T19:10:00.000+03:00", "crawled": "2018-04-27T16:52:27.000+03:00", "highlightTitle": ""}